TMJ Arthroscopy Compared to Arthrocentesis in Disc Displacement Without Reduction
Launched by KAROLINSKA INSTITUTET · Jan 13, 2025
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to compare two surgical methods for treating a painful condition called temporomandibular joint (TMJ) disc displacement without reduction, which can make it hard to open your mouth and cause significant pain. The two methods being compared are called arthroscopic lysis and lavage and arthrocentesis. The goal is to see which method better improves mouth opening, reduces pain, and helps people feel more capable in their daily lives.
To participate in this trial, you should be at least 18 years old and have difficulty opening your mouth due to TMJ disc displacement, with specific levels of pain and disability. Participants will have one of the two surgeries while under general anesthesia, but they won’t know which one they’re getting. After the surgery, they’ll have follow-up appointments at 1, 3, 6, 12, and 24 months to check on their recovery and complete surveys about their quality of life. The trial is not currently recruiting participants, but it aims to gather valuable information on how to best treat this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Uni- or bilateral DDwoR affecting the patients mouth opening capacity to a range of ≤ 35 mm, verified with clinical and magnetic resonance imaging (MRI) findings.
- • TMJ pain ≥ 3 (NRS)
- • TMJ disability ≥ 3 (NRS)
- • Age ≥ 18 years
- Exclusion Criteria:
- • Prior open TMJ surgery
- • Patient diagnosed with rheumatologic joint disease.
- • ASA (American Society of Anaesthesiologists) \> 3
- • Patient unable to verify informed consent.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Huddinge, , Sweden
Patients applied
Trial Officials
Mattias Ulmner, DDS, PhD
Principal Investigator
Karolinska Institutet, Department of Dental Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported